88 related articles for article (PubMed ID: 8165433)
1. Changes of rat blood and tissue cholinesterases following administration of tacrine derivatives in vivo.
Bajgar J; Skopec F
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(1-2):73-81. PubMed ID: 8165433
[TBL] [Abstract][Full Text] [Related]
2. Changes of cholinesterases in the blood and some tissues following administration of tacrin and its two derivatives to rats.
Bajgar J; Fusek J; Skopec F
Neurochem Int; 1994 Jun; 24(6):555-8. PubMed ID: 7981637
[TBL] [Abstract][Full Text] [Related]
3. Changes of cholinesterase activities in the plasma and some tissues following administration of L-carnitine and galanthamine to rats.
Bajgar J; Bartosova L; Fusek J; Svoboda Z; Herink J; Kvetina J; Palicka V; Zivny P; Blaha V
Neurosci Lett; 2007 Jan; 411(3):212-6. PubMed ID: 17125927
[TBL] [Abstract][Full Text] [Related]
4. Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptors.
Fang L; Jumpertz S; Zhang Y; Appenroth D; Fleck C; Mohr K; Tränkle C; Decker M
J Med Chem; 2010 Mar; 53(5):2094-103. PubMed ID: 20158205
[TBL] [Abstract][Full Text] [Related]
5. In vivo kinetics of blood cholinesterase inhibition by 9-amino-1, 2, 3, 4-tetrahydroacridine, its 7-methoxy derivative and physostigmine in rats.
Bajgar J; Fusek J; Patocka J; Hrdina V
Physiol Bohemoslov; 1979; 28(1):31-4. PubMed ID: 155828
[TBL] [Abstract][Full Text] [Related]
6. Tacrine and its analogues impair mitochondrial function and bioenergetics: a lipidomic analysis in rat brain.
Melo T; Videira RA; André S; Maciel E; Francisco CS; Oliveira-Campos AM; Rodrigues LM; Domingues MR; Peixoto F; Manuel Oliveira M
J Neurochem; 2012 Mar; 120(6):998-1013. PubMed ID: 22192081
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates.
Fang L; Appenroth D; Decker M; Kiehntopf M; Roegler C; Deufel T; Fleck C; Peng S; Zhang Y; Lehmann J
J Med Chem; 2008 Feb; 51(4):713-6. PubMed ID: 18232655
[TBL] [Abstract][Full Text] [Related]
9. [Biotransformation of the anticholinesterase agent, 9-amino-7-methoxy-1,2,3,4-tetrahydroacridine].
Patocka J; Bielavský J
Cesk Farm; 1991 May; 40(3):130-2. PubMed ID: 2070431
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cholinesterase inhibitory activity of 6-, 7-methoxy-(and hydroxy-) tacrine derivatives.
Del Giudice MR; Borioni A; Mustazza C; Gatta F; Meneguz A; Volpe MT
Farmaco; 1996 Nov; 51(11):693-8. PubMed ID: 9035375
[TBL] [Abstract][Full Text] [Related]
11. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang H; Tang XC
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753
[TBL] [Abstract][Full Text] [Related]
12. Effect of 7-methoxytacrine and L-carnitine on the activity of choline acetyltransferase.
Bajgar J; Skopec F; Herink J; Patocka J; Kvetina J
Gen Physiol Biophys; 1999 Oct; 18 Spec No():3-6. PubMed ID: 10703712
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of huperzine B on cholinesterase activity in mice.
Liu J; Zhang HY; Wang LM; Tang XC
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):141-5. PubMed ID: 10437161
[TBL] [Abstract][Full Text] [Related]
14. Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues.
Svoboda Z; Kvetina J; Kunesová G; Herink J; Bajgar J; Bartosová L; Zivný P; Palicka V
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():183-6. PubMed ID: 17159811
[TBL] [Abstract][Full Text] [Related]
15. Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity.
Butini S; Guarino E; Campiani G; Brindisi M; Coccone SS; Fiorini I; Novellino E; Belinskaya T; Saxena A; Gemma S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5213-6. PubMed ID: 18786825
[TBL] [Abstract][Full Text] [Related]
16. Distribution of tacrine and metabolites in rat brain and plasma after single- and multiple-dose regimens. Evidence for accumulation of tacrine in brain tissue.
McNally WP; Pool WF; Sinz MW; Dehart P; Ortwine DF; Huang CC; Chang T; Woolf TF
Drug Metab Dispos; 1996 Jun; 24(6):628-33. PubMed ID: 8781777
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the therapeutic efficacy of some antimuscarinics against soman in vivo.
Lau WM; Lewis KJ; Dawson RM
J Appl Toxicol; 1996; 16(5):423-30. PubMed ID: 8889794
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of bis(7)-tacrine inhibition of GABA-activated current in cultured rat hippocampal neurons.
Zhou L; Liu YW; Peoples RW; Yang M; Tian X; Ai YX; Pang YP; Li ZW; Han YF; Li CY
Neuropharmacology; 2009 Jul; 57(1):33-40. PubMed ID: 19393253
[TBL] [Abstract][Full Text] [Related]
19. Comparison studies of tacrine and bis7-tacrine on the suppression of scopolamine-induced behavioral changes and inhibition of acetylcholinesterase in mice.
Pan SY; Yu ZL; Xiang CJ; Dong H; Fang HY; Ko KM
Pharmacology; 2009; 83(5):294-300. PubMed ID: 19365154
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NMDA-gated ion channels by bis(7)-tacrine: whole-cell and single-channel studies.
Liu YW; Luo JL; Ren H; Peoples RW; Ai YX; Liu LJ; Pang YP; Li ZW; Han YF; Li CY
Neuropharmacology; 2008 Jun; 54(7):1086-94. PubMed ID: 18407299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
